CORT · Corcept Therapeutics Inc

$90.88 -4.77 (-4.99%) At close · Jul 22

Market Cap

$9.76B

107.35M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph K. Belanoff	CEO	$1,182,333	$1,190,000	—	$12,907,718	—	$23,500	$15,303,551
Charles Robb	Chief Business Officer	$711,413	$358,000	$124,500	$5,163,087	—	$23,500	$6,380,500
William Guyer	Chief Development Officer	$706,387	$429,600	$17,871	$5,163,087	—	$23,500	$6,340,445
Sean Maduck	President, Endocrinology Division	$648,860	$261,200	$111,995	$5,163,087	—	$23,500	$6,208,642
Atabak Mokari	CFO	$566,347	$285,000	$97,733	$5,163,087	—	$23,500	$6,135,667

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph K. Belanoff	CEO	$1,140,533	$1,716,000	—	$7,010,548	—	$23,000	$9,890,081
Charles Robb	Chief Business Officer	$686,273	$533,572	$91,307	$2,804,219	—	$23,000	$4,138,371
William Guyer	Chief Development Officer	$656,210	$510,198	—	$2,804,219	—	$23,000	$3,993,627
Sean Maduck	President, Endocrinology Division	$626,148	$471,120	$46,684	$2,804,219	—	$23,000	$3,971,171
Atabak Mokari	CFO	$546,323	$411,060	$72,704	$2,804,219	—	$23,000	$3,857,306

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph K. Belanoff	CEO	$1,083,333	$1,320,000	—	$6,911,901	—	$22,500	$9,337,734
Charles Robb	Chief Business Officer	$659,333	$397,200	$112,925	$2,764,760	—	$22,500	$3,956,718
Corcept Endocrinology	—	$601,583	$422,800	$97,288	$2,764,760	—	$22,500	$3,908,931
Sean Maduck	President, Endocrinology Division	$601,583	$422,800	$97,288	$2,764,760	—	$22,500	$3,908,931
William Guyer	Chief Development Officer	$628,167	$379,800	$60,871	$2,764,760	—	$22,602	$3,856,200
Atabak Mokari	CFO	$524,333	$316,200	$89,314	$2,764,760	—	$22,500	$3,717,107

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph K. Belanoff	CEO	$895,833	$900,000	—	$5,536,424	—	$20,500	$7,352,757
Corcept Endocrinology	—	$572,917	$230,000	$23,954	$2,866,685	—	$20,500	$3,714,056
Sean Maduck	President, Endocrinology Division	$572,917	$230,000	$23,954	$2,866,685	—	$20,500	$3,714,056
Charles Robb	Chief Business Officer	$627,500	$315,000	$26,240	$2,214,569	—	$20,500	$3,203,809
Hazel Hunt	Chief Scientific Officer	$572,917	$316,250	—	$2,214,569	—	$5,989	$3,109,725
William Guyer	Chief Development Officer	$572,917	$345,000	$23,954	$1,107,285	—	$20,500	$2,069,656
Atabak Mokari	CFO	$492,750	$247,500	$20,602	$1,107,285	—	$20,500	$1,888,637

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph K. Belanoff	CEO	$843,750	$850,000	—	$9,290,888	—	—	$10,984,638
Atabak Mokari	CFO	$390,000	$219,977	—	$6,411,662	—	—	$7,021,639
William Guyer	Chief Development Officer	$206,742	$247,500	—	$6,094,183	—	—	$6,548,425
Charles Robb	Chief Business Officer	$562,575	$337,500	—	$4,357,521	—	—	$5,257,596
Hazel Hunt	Chief Scientific Officer	$517,292	$309,375	—	$3,716,355	—	$6,661	$4,549,683
Sean Maduck	President, Endocrinology Division	$519,451	$309,375	—	$3,716,355	—	—	$4,545,181

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph K. Belanoff	CEO	$769,567	$744,000	—	$4,237,643	—	$10,892	$5,762,102
Sean Maduck	President, Endocrinology Division	$474,380	$214,157	—	$2,508,404	—	—	$3,196,941
Charles Robb	Chief Business Officer	$474,380	$321,236	—	$2,118,822	—	—	$2,914,438
Hazel Hunt	Chief Scientific Officer	$431,873	$243,000	—	$2,084,640	—	$6,180	$2,765,693
Andreas Grauer	Chief Medical Officer	$454,550	$219,157	—	$1,271,293	—	$118,274	$2,063,274

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph K. Belanoff	CEO	$707,525	$745,290	—	$3,506,155	—	—	$4,958,970
Andreas Grauer	Chief Medical Officer	$362,267	$243,720	—	$3,115,335	—	$78,245	$3,799,567
Charles Robb	CFO	$456,133	$308,881	—	$1,845,345	—	—	$2,610,359
Sean Maduck	President, Endocrinology Division	$456,133	$308,881	—	$1,476,276	—	—	$2,241,290

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph K. Belanoff	CEO	$679,792	$477,750	—	$5,157,075	—	—	$6,314,617
Charles Robb	Chief Business Officer	$436,667	$237,600	—	$2,171,400	—	—	$2,845,667
Sean Maduck	President, Endocrinology Division	$436,667	$198,000	—	$2,171,400	—	—	$2,806,067

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph K. Belanoff	CEO	$647,333	$702,000	—	$2,922,119	—	—	$4,271,452
Sean Maduck	President, Endocrinology Division	$397,917	$320,000	—	$2,036,818	—	—	$2,754,735
Charles Robb	CFO	$397,929	$320,000	—	$1,062,589	—	—	$1,780,518

Key facts CIK 1088856 CUSIP 218352102 13F (30d) 63 filings 62 filers Visit website Investor relations